Advances in breast cancer treatment: the emerging role of ixabepilone. - Wikidata - thesis-toulmin - TriplyDB

Advances in breast cancer treatment: the emerging role of ixabepilone.

Advances in breast cancer treatment: the emerging role of ixabepilone.

http://www.wikidata.org/entity/Q37656206

about

Tissue distribution and tumor uptake of folate receptor-targeted epothilone folate conjugate, BMS-753493, in CD2F1 mice after systemic administration.

P2860

Q37302203-D19F8AA0-5FAD-4930-B75A-590B8F6F9A1B

P2860

Advances in breast cancer treatment: the emerging role of ixabepilone.

http://www.wikidata.org/entity/Q37656206

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Advances in breast cancer treatment: the emerging role of ixabepilone.

@en

Advances in breast cancer treatment: the emerging role of ixabepilone.

@nl

type

label

Advances in breast cancer treatment: the emerging role of ixabepilone.

@en

Advances in breast cancer treatment: the emerging role of ixabepilone.

@nl

prefLabel

Advances in breast cancer treatment: the emerging role of ixabepilone.

@en

Advances in breast cancer treatment: the emerging role of ixabepilone.

@nl

P1433

Q37656206-3272E5B8-D9B0-4129-8686-8F468C8BAD67

P1476

Q37656206-8F8DBF5F-292C-4005-84E8-3C6523D7313A

P2093

Q37656206-07C7F000-FC09-4AF8-B209-8F088EA441AA

P2860

Q37656206-0148F057-EFBF-405A-9213-48468F7A91AD

Q37656206-1830E835-3ACA-4584-AF26-AB53159C4055

Q37656206-1ED40F77-1708-4080-B9B0-9AC9FB5CFA72

Q37656206-2CA2659D-8A53-4CB0-AD44-4FD04A236CA0

Q37656206-363649F9-A718-472F-BABC-74C7B74978FA

Q37656206-4BF0DD22-60BD-463F-8F5D-32FCB30CE2FA

Q37656206-7147B7A8-CA07-4911-9CD5-3CF824BFB741

Q37656206-9B09035B-23AF-4916-A29A-A5C4F43D4F7F

Q37656206-BF2FD861-F479-4103-89F5-09B3DC9F754F

Q37656206-C068E5B7-0534-4340-900A-1FBA2F55560E

P304

Q37656206-43267F0D-4C1B-482E-BB2D-15F103CD34EC

P31

Q37656206-40FEE45B-7935-4E00-B8C4-85013B7D7838

P356

Q37656206-064D0409-8707-4F56-BD58-ECD2EEA725EF

P433

Q37656206-0DD0A42B-2CB1-463D-9A04-F7C77265DCC1

P478

Q37656206-4BF59E7A-2C32-4CE5-863A-0E3F71E9814C

P577

Q37656206-06CB6293-437D-4707-81FC-3C56A033B1C5

P698

Q37656206-C1F3FE07-DB09-4278-88AC-8199113CB631

P356

P1433

Expert Review of Anticancer Therapy

P1476

Advances in breast cancer treatment: the emerging role of ixabepilone.

@en

P2093

Debra K Frye

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2008

Ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment

Epothilones: mechanism of action and biologic activity

THE DEVELOPMENT AND CLINICAL UTILITY OF THE TAXANE CLASS OF ANTIMICROTUBULE CHEMOTHERAPY AGENTS

Epothilone B and its analogs - a new family of anticancer agents.

Chemotherapy induced diarrhea.

Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. 304 Study Group.

Desoxyepothilone B: an efficacious microtubule-targeted antitumor agent with a promising in vivo profile relative to epothilone B.

Microtubule stabilizing agents: their molecular signaling consequences and the potential for enhancement by drug combination.

Peripheral neuropathy induced by microtubule-stabilizing agents.

P304

23-32

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERA.09.158

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20014882

http://www.w3.org/2001/XMLSchema#string